The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index; none of the 30 sources its claims cite is checked for support yet.
Cardiovascular autonomic dysfunction in Ehlers–Danlos syndrome—Hypermobile type
Open accessAbstract
Autonomic dysfunction contributes to health‐related impairment of quality of life in the hypermobile type of Ehlers–Danlos syndrome (hEDS). Typical signs and symptoms include tachycardia, hypotension, gastrointestinal dysmotility, and disturbed bladder function and sweating regulation. Cardiovascular autonomic dysfunction may present as Orthostatic Intolerance, Orthostatic Hypotension, Postural Orthostatic Tachycardia Syndrome, or Neurally Mediated Hypotension. The incidence, prevalence, and natural history of these conditions remain unquantified, but observations from specialist clinics suggest they are frequently seen in hEDS. There is growing understanding of how hEDS‐related physical and physiological pathology contributes to the development of these conditions. Evaluation of cardiovascular symptoms in hEDS should include a careful history and clinical examination. Tests of cardiovascular function range from clinic room observation to tilt‐table assessment to other laboratory investigations such as supine and standing catecholamine levels. Non‐pharmacologic treatments include education, managing the environment to reduce exposure to triggers, improving cardiovascular fitness, and maintaining hydration. Although there are limited clinical trials, the response to drug treatments in hEDS is supported by evidence from case and cohort observational data, and short‐term physiological studies. Pharmacologic therapy is indicated for patients with moderate‐severe impairment of daily function and who have inadequate response or tolerance to conservative treatment. Treatment in hEDS often requires a focus on functional maintenance. Also, the negative impact of cardiovascular symptoms on physical and psycho‐social well‐being may generate a need for a more general evaluation and on‐going management and support. © 2017 Wiley Periodicals, Inc.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
37 No basis given · 21 Not checked yet · 7 Own interpretation · 1 Sources not found
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The incidence, prevalence, and natural history of these conditions remain unquantified, but observations from specialist clinics suggest they are frequently seen in hEDS.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > Abstract
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Autonomic dysfunction contributes to health-related impairment of quality of life in the hypermobile type of Ehlers-Danlos syndrome (hEDS).”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > Abstract
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“and an intriguing association reported between multi-systemic pathologies including autonomic disturbances and germline duplications and triplications of the TSPAB1 gene encoding alpha 1 tryptase [Lyons et al., 2016].”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > EVIDENCE FOR UNDERLYING MECHANISMS IN hEDS
What the sources say
- Not checked yetcites Lyons et al., 2016
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Symptoms can be highly debilitating in hEDS [Rowe et al., 1999;Hakim and Grahame, 2004;Mathias et al., 2011;De Wandele et al., 2014b].”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > LITERATURE REVIEW
What the sources say
- Not checked yetcites Rowe et al., 1999
- Not checked yetcites Hakim and Grahame, 2004
- Not checked yetcites Mathias et al., 2011
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The incidence, prevalence, and natural history of these conditions remain unquantified, but observations from specialist clinics suggest they are frequently seen in hEDS.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > Abstract
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
In the paper
“MVP is not common (approx.6%) in patients with hEDS [Dolan et al., 1997;McDonnell et al., 2006;Atzinger et al., 2011], and in most cases this is unlikely to be of clinical significance.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > CONTROVERSIES Screening for Mitral Valve Prolapse
What the sources say
- Not checked yetcites Dolan et al., 1997;McDonnell et al., 2006;Atzinger et al., 2011
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In some cases this may also be a contributing factor”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > EVIDENCE FOR UNDERLYING MECHANISMS IN hEDS
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“MVP is not common (approx.6%) in patients with hEDS [Dolan et al., 1997;McDonnell et al., 2006;Atzinger et al., 2011], and in most cases this is unlikely to be of clinical significance.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > CONTROVERSIES Screening for Mitral Valve Prolapse
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Gazit et al. [2003] identified evidence of alpha-adrenergic and betaadrenergic hyper-responsiveness.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > CAUSAL ASSOCIATIONS WITH hEDS
What the sources say
- Not checked yetcites Gazit et al. [2003]
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“High circulating levels of histamine may be another mechanism contributing to cardiovascular dysfunction”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > EVIDENCE FOR UNDERLYING MECHANISMS IN hEDS
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 28
- Probably not a substantial claim. 33
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Equally the causal relationships in hEDS are unclear though there are plausible mechanisms, and the evidence for the management in hEDS is lacking in that there are no published clinical trials.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > LITERATURE REVIEW
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“However, there are no clinical trials of treatment in hEDS, either in general or in specific subgroups based on pathophysiology.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > Symptoms can be highly debilitating in hEDS.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“There has been no general hEDS population cohort study of cardiovascular autonomic dysfunction, and there has been one published case-control study of symptom reporting.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > LITERATURE REVIEW
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Equally the causal relationships in hEDS are unclear though there are plausible mechanisms, and the evidence for the management in hEDS is lacking in that there are no published clinical trials.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > LITERATURE REVIEW
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The causes of cardiovascular autonomic dysfunction in hEDS are unclear.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > CAUSAL ASSOCIATIONS WITH hEDS
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In the general literature on the management of autonomic dysfunction there is evidence for the effectiveness of treatment strategies.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > Symptoms can be highly debilitating in hEDS.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Even where evidence exists, it is confounded by imprecision in definitions and diagnostic methods that further confound extrapolation from data to individual patients.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > MANAGEMENT AND CARE GUIDELINES
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: fails — It may be too vague to check against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may be too vague to check against evidence. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“There is no evidence that specific treatments should be targeted at subgroups of patients with hEDS.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > Treatment
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Level IV evidence of the associations with EDS arises from small cohort studies, case reports, and expert opinion.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > MANAGEMENT AND CARE GUIDELINES
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
In the paper
“As such guidance is principally based on expert consensus, but draws on Level I to III guidance published by international groups on the assessment and management of POTS and OI per se [Grubb et al., 2006;Lahrmann et al., 2006;Sheldon et al., 2015].”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > MANAGEMENT AND CARE GUIDELINES
What the sources say
- Not checked yetcites Grubb et al., 2006;Lahrmann et al., 2006;Sheldon et al., 2015
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The incidence, prevalence, and natural history of cardiovascular autonomic dysfunction in the hEDS population are unknown, as are the distribution and types of (co-associated) mechanisms that may trigger or influence these phenomena.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > WHAT WE NEED TO KNOW
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Using the standard nomenclature for guidelines Level I to III evidence for the management of cardiovascular autonomic dysfunction in hEDS is lacking; there are no published clinical trials.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > MANAGEMENT AND CARE GUIDELINES
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Typical signs and symptoms include tachycardia, hypotension, gastrointestinal dysmotility, and disturbed bladder function and sweating regulation.”
- Also stated in: § INTRODUCTION AND METHODS · plain
“While many symptoms of autonomic dysfunction have been observed clinically in hEDS, including cardiovascular, pupil, bladder, sweating dysfunction, and gastrointestinal dysmotility (see”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > Abstract
What the sources say
- Not checked yetcites Aziz et al.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Also stated in: § INTRODUCTION AND METHODS · plain
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Mitral valve prolapse (MVP) can be associated with excessive catecholamines, orthostatic intolerance, and occasionally with dysrhythmias.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > CONTROVERSIES Screening for Mitral Valve Prolapse
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Rowe et al. [1999] suggested that in some cases the association of OI with hEDS could be attributed to abnormal connective tissue in dependent blood vessels with veins distending excessively in response to ordinary hydrostatic pressures.This in turn leads to increased venous pooling and its hemodynamic and symptomatic consequences.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > CAUSAL ASSOCIATIONS WITH hEDS
What the sources say
- Not checked yetcites Rowe et al. [1999]
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“There is recognition of an association of POTS with fatigue [Schondorf et al., 1999], reduced quality of life [Benrud-Larson et al., 2002], and a greater incidence of migraine and syncope with POTS in patients with joint hypermobility syndrome compared to those without [Kanjwal et al., 2010].”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > LITERATURE REVIEW
What the sources say
- Not checked yetcites Schondorf et al., 1999
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“When poorly controlled, these symptoms may also restrict treatment strategies for other symptomatic management including physical therapies.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > LITERATURE REVIEW
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Histamine can induce hypotension and tachycardia [Frieri et al., 2013].”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > EVIDENCE FOR UNDERLYING MECHANISMS IN hEDS
What the sources say
- Not checked yetcites Frieri et al., 2013
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“There is growing recognition of an association between autonomic dys-function and Ehlers-Danlos syndrome -hypermobile type (hEDS).”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > INTRODUCTION AND METHODS
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: fails — It may be too vague to check against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. It may be too vague to check against evidence. The paper may give no reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Studies by Mathias et al. [2011] and De Wandele et al. [2014a] suggest that neuropathy, connective tissue laxity, and vasoactive medication play a role in development of cardiovascular dysfunction in hEDS.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > CAUSAL ASSOCIATIONS WITH hEDS
What the sources say
- Not checked yetcites Mathias et al. [2011]
- Not checked yetcites De Wandele et al. [2014a]
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim could be matched to a paper in Crossref, so there is nothing to check it against.
In the paper
“Also in the general literature, research has identified potentially pathogenic adrenergic [Fedorowski et al., 2016], muscarinic [Yu et al., 2012;Dubey et al., 2016], and other neural autoantibodies [Thieben et al., 2007;Li et al., 2014;Singer et al., 2016] in a significant percentage of cases with POTS and a subset of those with OH.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > CAUSAL ASSOCIATIONS WITH hEDS
What the sources say
- Not matchedcites Fedorowski et al., 2016
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites Yu et al., 2012;Dubey et al., 2016
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites Thieben et al., 2007;Li et al., 2014;Singer et al., 2016
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Not matched
In the paper
“There is recognition of an association of POTS with fatigue [Schondorf et al., 1999], reduced quality of life [Benrud-Larson et al., 2002], and a greater incidence of migraine and syncope with POTS in patients with joint hypermobility syndrome compared to those without [Kanjwal et al., 2010].”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > LITERATURE REVIEW
What the sources say
- Not checked yetcites Kanjwal et al., 2010
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“There is recognition of an association of POTS with fatigue [Schondorf et al., 1999], reduced quality of life [Benrud-Larson et al., 2002], and a greater incidence of migraine and syncope with POTS in patients with joint hypermobility syndrome compared to those without [Kanjwal et al., 2010].”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > LITERATURE REVIEW
What the sources say
- Not checked yetcites Benrud-Larson et al., 2002
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“In support of the hypothesis that this is one mechanism in hEDS, a study by Thieben et al. [2007] identified a hyperadrenergic state in 29% of cases of POTS from a general cohort though cases of hEDS were not specifically identified.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > CAUSAL ASSOCIATIONS WITH hEDS
What the sources say
- Not checked yetcites Thieben et al. [2007] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Also, normal cardiac anatomy does not rule out cardiovascular dysfunction.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > CONTROVERSIES Screening for Mitral Valve Prolapse
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Suggested mechanisms include (listed based on clinical experience and in order of most common occurrence): Low blood pressure, increased peripheral venous dilation and blood pooling, low circulating blood volume, medications with side effects that trigger or impair autonomic responses, for example tricyclics, elevated circulating catecholamines, auto-immunity, particularly auto-antibodies directed”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > CAUSAL ASSOCIATIONS WITH hEDS
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Many of the common symptoms relate to changes in posture.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > History
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The prognosis remains uncertain with the outcomes ranging from virtually complete resolution of symptoms to long-term disability, which may be so severe as to affect education, employment, or socialization.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > SUMMARY
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Fu et al. [2011] and George et al. [2016] have shown that after a 3-month training programme, moderate gradual endurance and strength training can decrease upright heart rate, improve baroreflex sensitivity and heart rate variability, and improve quality of life.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > CONTROVERSIES Screening for Mitral Valve Prolapse
What the sources say
- Not checked yetcites Fu et al., 2011
- Not checked yetcites George et al., 2016
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Physical deconditioning and poor aerobic fitness are common findings in patients chronically unwell with hEDS.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > CONTROVERSIES Screening for Mitral Valve Prolapse
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Symptoms of OI can overlap with some features of cardiac dysrhythmias.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > Physical examination
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Fludrocortisone is a first line drug therapy for OI at doses of 100-200 mg daily (Level III evidence).”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > Treatment
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
- Rests on an assumption: Treatments shown to be effective for POTS and OI in the general population are also effective for cardiovascular autonomic dysfunction in hEDS.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Dihydroxyphenylserine titrated 100-200 mg three times daily reduces OH (Level I evidence).”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > Treatment
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
- Rests on an assumption: Treatments shown to be effective for POTS and OI in the general population are also effective for cardiovascular autonomic dysfunction in hEDS.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“A simple clinic room standing test can help assess whether a brief period of standing can provoke orthostatic symptoms in those with NMH, but provocation of hypotension usually requires more prolonged tilt table testing.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > Physical examination
plainconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Individuals with hEDS can develop cardiovascular autonomic dysfunction.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > SUMMARY
plainconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“They occur when changing from a lying or sitting to a standing position, or with maintaining upright posture, and are improved but not always completely relieved by sitting or lying down.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > History
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. It may state two separate claims as one.
In the paper
“Pyridostigmine is a peripheral acetylcholinesterase inhibitor that increases synaptic acetylcholine in the autonomic ganglia and at peripheral muscarinic receptors [Raj et al., 2005].The drug can be effective for neurally mediated syncope and for POTS (Level I evidence).”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > Treatment
What the sources say
- Not checked yetcites Raj et al., 2005
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Treatments shown to be effective for POTS and OI in the general population are also effective for cardiovascular autonomic dysfunction in hEDS.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The diagnosis of NMH that is associated with recurrent syncope can be made clinically, and in most cases does not require formal tilt table testing.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > Physical examination
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The diagnosis is predominantly based upon taking a detailed personal and family history of symptoms, provoking circumstances, and accompanying complaints.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > SUMMARY
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Simple clinic room tests can provide support for the diagnosis and other tests may be useful to exclude other diseases that can present in a similar manner.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > SUMMARY
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Specific conditions include POTS and NMH.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > SUMMARY
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“None of the treatments available is universally effective, and several treatments, used together, are likely to be needed.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > Treatment
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“POTS, OH, and some forms of OI can be diagnosed in clinic without the need for complex tests.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > Physical examination
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Midodrine significantly reduces POTS symptoms and reduces the frequency of neurally mediated syncope (Level I evidence).”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > Treatment
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Treatments shown to be effective for POTS and OI in the general population are also effective for cardiovascular autonomic dysfunction in hEDS.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Ivabradine slows sinus heart rate without affecting blood pressure, and has been reported to be helpful in those with POTS (Level III evidence).”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > Treatment
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Treatments shown to be effective for POTS and OI in the general population are also effective for cardiovascular autonomic dysfunction in hEDS.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Its manifestations include symptoms related to inadequate cerebral perfusion and symptoms of heightened adrenergic tone.”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > SUMMARY
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Beta blockers can help with management of recurrent syncope, NMH, POTS, and OI (Level I evidence).”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > Treatment
plainconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Treatments shown to be effective for POTS and OI in the general population are also effective for cardiovascular autonomic dysfunction in hEDS.
The paper relies on this without support.
Treatments shown to be effective for POTS and OI in the general population are also effective for cardiovascular autonomic dysfunction in hEDS.
“Such treatments have been applied to individual cases of hEDS, based on physiological findings.However, there are no clinical trials of treatment in hEDS, either in general or in specific subgroups based on pathophysiology.”
“As such guidance is principally based on expert consensus, but draws on Level I to III guidance published by international groups on the assessment and management of POTS and OI per se [Grubb et al., 2006;Lahrmann et al., 2006;Sheldon et al., 2015].”
The paper relies on this without support.
The consensus definitions of POTS, OH, NMH, and OI developed for general populations are valid for diagnosing these conditions in hEDS.
“The following consensus definitions 1 [Freeman et al., 2011;Sheldon et al., 2015] are applied:”
“This document uses definitions already proposed by international consensus and published in the general literature.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Clinical features of HSD and hEDS are not limited to musculoskeletal and cutaneous symptoms (9). Associations exist with cardiovascular autonomic dysfunction (12), gastrointestinal difficulties (13), fatigue (12) and pain syndromes (14), gynecological and obstetric problems (15, 16), and mental health concerns (17–19).”
From Joint Hypermobility Links Neurodivergence to Dysautonomia and Pain (2022) · cites this paper as [12]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Symptoms of orthostatic intolerance can be debilitating (12).”
From Joint Hypermobility Links Neurodivergence to Dysautonomia and Pain (2022) · cites this paper as [12]
In the citing paper
“Cardiovascular autonomic dysfunction can include orthostatic hypotension, orthostatic intolerance, neurally‐mediated hypotension and postural orthostatic tachycardia syndrome (PoTS), the latter of which is commonly associated with HSD/hEDS. 66”
From Hypermobile Ehlers–Danlos syndrome and disorders of the gastrointestinal tract: What the gastroenterologist needs to know (2022) · cites this paper as [66]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > EVIDENCE FOR UNDERLYING MECHANISMS IN hEDS
“germline duplications and triplications of the TSPAB1 gene encoding alpha 1 tryptase [Lyons et al., 2016].”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > References
“Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > Physical examination
“(iii) the absence of orthostatic hypotension (>20 mm Hg drop in systolic blood pressure).”
§ Cardiovascular Autonomic Dysfunction in Ehlers-Danlos Syndrome-Hypermobile Type > Physical examination
“OH: a sustained reduction of systolic blood pressure by at least 20 mm Hg systolic or diastolic blood pressure of at least 10 mm Hg within 3 min of standing or head-up tilt to at least 60° angle on a tilt table.”
Citations
Cites
Freeman, R., Wieling, W., Axelrod, F. B., Benditt, D. G., Benarroch, E., Biaggioni, I., Cheshire, W. P., Chelimsky, T., Cortelli, P., Gibbons, C. H., et al. (2011) · Clinical Autonomic Research · doi:10.1007/s10286-011-0119-5 · Cited by 1,697 · cited 1×
“The following consensus definitions1 [Freeman et al., 2011; Sheldon et al., 2015] are applied: POTS: is a clinical syndrome usually characterized by: (i) frequent symptoms that occur with standing, such as lightheadedness, palpitations, tremor, generalized weakness, blurred vision, exercise…”
MethodSheldon, R. S., Grubb, B. P., Olshansky, B., Shen, W.-K., Calkins, H., Brignole, M., Raj, S. R., Krahn, A. D., Morillo, C. A., Stewart, J. M., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.03.029 · Cited by 1,013
Postural orthostatic tachycardia syndrome: the Mayo clinic experience
Thieben, M. J., Sandroni, P., Sletten, D. M., Benrud-Larson, L. M., Fealey, R. D., Vernino, S., Low, P. A., Lennon, V. A., & Shen, W.-K. (2007) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)61027-6 · Cited by 516
Lyons, J. J., Yu, X., Hughes, J. D., Le, Q. T., Jamil, A., Bai, Y., Ho, N., Zhao, M., Liu, Y., O'Connell, M. P., et al. (2016) · Nature Genetics · doi:10.1038/ng.3696 · Cited by 394
Dysautonomia in the joint hypermobility syndrome
Gazit, Y., Nahir, A. M., Grahame, R., & Jacob, G. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00235-3 · Cited by 390
EFNS guidelines on the diagnosis and management of orthostatic hypotension
Lahrmann, H., Cortelli, P., Hilz, M., Mathias, C. J., Struhal, W., & Tassinari, M. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01512.x · Cited by 334 · cited 2×
“As such guidance is principally based on expert consensus, but draws on Level I to III guidance published by international groups on the assessment and management of POTS and OI per se [Grubb et al., 2006; Lahrmann et al., 2006; Sheldon et al., 2015].”
BackgroundCardiac origins of the postural orthostatic tachycardia syndrome
Fu, Q., VanGundy, T. B., Galbreath, M. M., Shibata, S., Jain, M., Hastings, J. L., Bhella, P. S., & Levine, B. D. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.02.043 · Cited by 329
Di Girolamo, E., Di Iorio, C., Sabatini, P., Leonzio, L., Barbone, C., & Barsotti, A. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00694-9 · Cited by 322
Milhorat, T. H., Bolognese, P. A., Nishikawa, M., McDonnell, N. B., & Francomano, C. A. (2007) · Journal of Neurosurgery Spine · doi:10.3171/spi-07/12/601 · Cited by 256
Autoimmune Basis for Postural Tachycardia Syndrome
Li, H., Yu, X., Liles, C., Khan, M., Vanderlinde‐Wood, M., Galloway, A., Zillner, C., Benbrook, A., Reim, S., Collier, D., et al. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000755 · Cited by 255
Research works printed but not linked: 4
- Cheung I, 2015, A new disease cluster: Mast Cell Activation syndrome, Postural Orthostatic Tachycardia syndrome, & Ehlers‐Danlos syndrome, J Allergy Clin lmmunol, 35, AB 209
- Dubey D, 2016, M1 and M2 muscarinic receptor antibodies among patients with postural orthostatic tachycardia syndrome: Potential disease biomarker, J Clin Neuromuscul Dis, 17, 179
- Louisias M, 2013, Prevalence of allergic disorders and mast cell activation syndrome in patients with Ehlers Danlos syndrome, Ann Allergy Asthma lmmunol, 111, A12
- Singer W, 2016, Autoantibodies in the postural tachycardia syndrome, Clin Auton Res, 24, 214
Cited by
Sorted by citations
Demmler, J. C., Atkinson, M. D., Reinhold, E. J., Choy, E., Lyons, R. A., & Brophy, S. T. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-031365 · Cited by 271
Gensemer, C., Burks, R., Kautz, S. A., Judge, D. P., Lavallee, M. E., & Norris, R. A. (2020) · Developmental Dynamics · doi:10.1002/dvdy.220 · Cited by 163
Postural tachycardia syndrome and other forms of orthostatic intolerance in Ehlers-Danlos syndrome
Roma, M., Marden, C. L., De Wandele, I., Francomano, C. A., & Rowe, P. C. (2018) · Autonomic Neuroscience · doi:10.1016/j.autneu.2018.02.006 · Cited by 133
Self-citationKucharik, A. H., & Chang, C. (2020) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-019-08755-8 · Cited by 122
Diagnosis and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Grach, S. L., Seltzer, J. L., Chon, T. Y., & Ganesh, R. (2023) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2023.07.032 · Cited by 116
Contemporary approach to joint hypermobility and related disorders
Castori, M., & Hakim, A. (2017) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000541 · Cited by 105
Self-citationThe Relationship between Autism and Ehlers-Danlos Syndromes/Hypermobility Spectrum Disorders
Casanova, E. L., Baeza-Velasco, C., Buchanan, C. B., & Casanova, M. F. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10040260 · Cited by 109
Joint Hypermobility Links Neurodivergence to Dysautonomia and Pain
Csecs, J. L. L., Iodice, V., Rae, C. L., Brooke, A., Simmons, R., Quadt, L., Savage, G. K., Dowell, N. G., Prowse, F., Themelis, K., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.786916 · Cited by 119
Postural Orthostatic Tachycardia Syndrome: Prevalence, Pathophysiology, and Management
Zadourian, A., Doherty, T. A., Swiatkiewicz, I., & Taub, P. R. (2018) · Drugs · doi:10.1007/s40265-018-0931-5 · Cited by 90
Mu, W., Muriello, M., Clemens, J. L., Wang, Y., Smith, C. H., Tran, P. T., Rowe, P. C., Francomano, C. A., Kline, A. D., & Bodurtha, J. (2019) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.61055 · Cited by 71
Self-citationLam, C. Y., Palsson, O. S., Whitehead, W. E., Sperber, A. D., Tornblom, H., Simren, M., & Aziz, I. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.02.034 · Cited by 71
The challenges of chronic pain and fatigue
Eccles, J., & Davies, K. A. (2021) · Clinical Medicine · doi:10.7861/clinmed.2020-1009 · Cited by 70
Mathias, C. J., Owens, A., Iodice, V., & Hakim, A. (2021) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31951 · Cited by 65
Self-citationThwaites, P. A., Gibson, P. R., & Burgell, R. E. (2022) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15927 · Cited by 59
Symptomatic joint hypermobility
Tinkle, B. T. (2020) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2020.101508 · Cited by 60
Symptomatic Joint Hypermobility
Tinkle, B. T., & Levy, H. P. (2019) · Medical Clinics of North America · doi:10.1016/j.mcna.2019.08.002 · Cited by 63
Eccles, J. A., Thompson, B., Themelis, K., Amato, M. L., Stocks, R., Pound, A., Jones, A.-M., Cipinova, Z., Shah-Goodwin, L., Timeyin, J., et al. (2021) · Clinical Medicine · doi:10.7861/clinmed.2020-0743 · Cited by 55
Copetti, M., Morlino, S., Colombi, M., Grammatico, P., Fontana, A., & Castori, M. (2019) · Rheumatology · doi:10.1093/rheumatology/kez029 · Cited by 55
Global warming, heat-related illnesses, and the dermatologist
Williams, M. L. (2021) · International Journal of Women's Dermatology · doi:10.1016/j.ijwd.2020.08.007 · Cited by 60
Diagnosis and Management of Hypermobility Spectrum Disorders in Primary Care
Atwell, K., Michael, W., Dubey, J., James, S., Martonffy, A., Anderson, S., Rudin, N., & Schrager, S. (2021) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2021.04.200374 · Cited by 52
Chohan, K., Mittal, N., McGillis, L., Lopez-Hernandez, L., Camacho, E., Rachinsky, M., Mina, D. S., Reid, W. D., Ryan, C. M., Champagne, K., et al. (2021) · Chronic Respiratory Disease · doi:10.1177/14799731211025313 · Cited by 55
Goldstein, D. S., & Cheshire, W. P. (2017) · Clinical Autonomic Research · doi:10.1007/s10286-017-0425-7 · Cited by 46
Ehlers-Danlos syndromes: state of the art on clinical practice guidelines
Sulli, A., Talarico, R., Scirè, C. A., Avcin, T., Castori, M., Ferraris, A., Frank, C., Grunert, J., Paolino, S., Bombardieri, S., et al. (2018) · RMD Open · doi:10.1136/rmdopen-2018-000790 · Cited by 44
Systemic manifestations of Ehlers-Danlos syndrome
Song, B., Yeh, P., & Harrell, J. (2021) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2020.1805714 · Cited by 43
Recognizing and Effectively Managing Hypermobility-Related Conditions
Russek, L. N., Stott, P., & Simmonds, J. V. (2019) · Physical Therapy · doi:10.1093/ptj/pzz078 · Cited by 46
McGillis, L., Mittal, N., Santa Mina, D., So, J., Soowamber, M., Weinrib, A., Soever, L., Rozenberg, D., Liu, L., Tse, Y., et al. (2020) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.61459 · Cited by 35
An Integrated Review of Carpal Tunnel Syndrome: New Insights to an Old Problem
Omole, A. E., Awosika, A., Khan, A., Adabanya, U., Anand, N., Patel, T. D., Edmondson, C. K., Fakoya, A. O. J., & Millis, R. M. (2023) · Cureus · doi:10.7759/cureus.40145 · Cited by 34
Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders.
Yew, K. S., Kamps-Schmitt, K. A., & Borge, R. (2021) · PubMed · Cited by 33
van Meulenbroek, T., Huijnen, I. P. J., Simons, L. E., Conijn, A. E. A., Engelbert, R. H. H., & Verbunt, J. A. (2021) · Scandinavian Journal of Pain · doi:10.1515/sjpain-2020-0023 · Cited by 30
“Autonomic dysfunction contributes to disability and decreased quality of life in G-HSD/hEDS [79, 81].”
BackgroundExtracutaneous features and complications of the Ehlers-Danlos syndromes: A systematic review
Doolan, B. J., Lavallee, M. E., Haußer, I., Schubart, J. R., Pope, F. M., Seneviratne, S. L., Winship, I., & Burrows, N. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1053466 · Cited by 32
Autistic Traits Correlate with Chronic Musculoskeletal Pain: A Self-Selected Population Based Survey
Ryan, L., Beer, H., Thomson, E., Philcox, E., & Kelly, C. (2023) · OBM Neurobiology · doi:10.21926/obm.neurobiol.2301155 · Cited by 29
Brooks, R. S., Grady, J., Lowder, T. W., & Blitshteyn, S. (2021) · Rheumatology · doi:10.1093/rheumatology/keaa926 · Cited by 28
Celletti, C., Borsellino, B., Castori, M., Censi, F., Calcagnini, G., Camerota, F., & Strano, S. (2020) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2020.1286 · Cited by 34
Maya, T. R., Fettig, V. M., Mehta, L., Gelb, B. D., & Kontorovich, A. (2021) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62446 · Cited by 30
Sandmann, W., Scholbach, T., & Verginis, K. (2021) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31949 · Cited by 25
Daylor, V., Griggs, M., Weintraub, A., Byrd, R. L., Petrucci, T., Huff, M. L., Byerly, K., Fenner, R., Severance, S., Griggs, C., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14165636 · Cited by 29
Resource utilization and multidisciplinary care needs for patients with Ehlers–Danlos syndrome
Jones, J. T., Black, W. R., Cogan, W., & Callen, E. F. (2022) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.2057 · Cited by 25
Ehlers–Danlos syndrome in a young woman with anorexia nervosa and complex somatic symptoms
Lee, M., & Strand, M. (2017) · International Journal of Eating Disorders · doi:10.1002/eat.22815 · Cited by 23
Masterclass: Hypermobility and hypermobility related disorders
Simmonds, J. V. (2022) · Musculoskeletal Science and Practice · doi:10.1016/j.msksp.2021.102465 · Cited by 21
Biomarkers for Ehlers-Danlos Syndromes: There Is a Role?
Caliogna, L., Guerrieri, V., Annunziata, S., Bina, V., Brancato, A. M., Castelli, A., Jannelli, E., Ivone, A., Grassi, F. A., Mosconi, M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810149 · Cited by 21
Respiratory manifestations in the Ehlers–Danlos syndromes
Bascom, R., Dhingra, R., & Francomano, C. A. (2021) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31953 · Cited by 23
Yao, L. E., Subramaniam, K., Raja, K. M., Arunachalam, A., Tran, A., Pandey, T., Ravishankar, S., Suggala, S., Hendrickson, C., & Maxwell, A. J. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1513199 · Cited by 22
Csecs, J. L. L., Dowell, N. G., Savage, G. K., Iodice, V., Mathias, C. J., Critchley, H., & Eccles, J. (2021) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31957 · Cited by 18
Baeza‐Velasco, C. (2021) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31946 · Cited by 17
Eccles, J., Cadar, D., Quadt, L., Hakim, A. J., Gall, N. P., Bowyer, V., Cheetham, N. J., Steves, C. J., Critchley, H., & Davies, K. A. (2024) · BMJ Public Health · doi:10.1136/bmjph-2023-000478 · Cited by 15
Self-citationHypermobile Ehlers-Danlos Syndrome: Cerebrovascular, Autonomic and Neuropathic Features
Novák, P., Systrom, D. M., Marciano, S. P., Witte, A. V., Warren, A., Felsenstein, D., Giannetti, M. P., Hamilton, M. J., Nicoloro‐SantaBarbara, J. M., Castells, M., et al. (2025) · American Journal of Medicine Open · doi:10.1016/j.ajmo.2025.100111 · Cited by 20
Ehlers-Danlos Syndromes, Joint Hypermobility and Hypermobility Spectrum Disorders
Micale, L., Fusco, C., & Castori, M. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-80614-9_9 · Cited by 17
Jones, J. T., & Black, W. R. (2022) · Global Pediatric Health · doi:10.1177/2333794x221112841 · Cited by 19
Peebles, K. C., Tan, I., Butlin, M., Collins, F., Tofts, L., Avolio, A. P., & Pacey, V. (2022) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62705 · Cited by 14
Wu, W. K. K., & Ho, V. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1379646 · Cited by 16
Huang, K. Z., & Dellon, E. S. (2019) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld.2014.1121.281.syd · Cited by 12
Hertel, A., Black, W. R., Malloy-Walton, L. E., Martin, J. R., & Jones, J. T. (2024) · Current Cardiology Reviews · doi:10.2174/011573403x271096231203164216 · Cited by 12
Choudhary, A., Fikree, A., & Aziz, Q. (2021) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31938 · Cited by 13
Mittal, N., Mina, D. S., Buryk-Iggers, S., Lopez-Hernandez, L., Hussey, L., Franzese, A., Katz, J. D., Laflamme, C., McGillis, L., McLean, L., et al. (2021) · Frontiers in Rehabilitation Sciences · doi:10.3389/fresc.2021.769792 · Cited by 13
Pietri-Toro, J., Gardner, O. K., Leuchter, J. D., DiBartolomeo, G., Hunter, J. A., & Forghani, I. (2023) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.63168 · Cited by 11
Black, W. R., Black, L. L., & Jones, J. T. (2023) · Global Pediatric Health · doi:10.1177/2333794x231212081 · Cited by 10
Joint hypermobility in children: a neglected sign needing more attention
Castori, M. (2020) · Minerva Pediatrics · doi:10.23736/s0026-4946.20.05766-7 · Cited by 11
Lamari, N. M., & Beighton, P. (2023) · In clinical practice · doi:10.1007/978-3-031-34914-0_7 · Cited by 10
Steinberg, R., Dicken, W., & Cutchins, A. C. (2023) · US Cardiology Review · doi:10.15420/usc.2022.35 · Cited by 11
McGregor, G., Hee, S. W., Eftekhari, H., Holliday, N., Pearce, G., Sandhu, H. K., Simmonds, J. V., Joshi, S., Kavi, L., Bruce, J., et al. (2020) · Pilot and Feasibility Studies · doi:10.1186/s40814-020-00702-1 · Cited by 10
Baban, A., & Castori, M. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1497973 · Cited by 10
Ryan, L., Beer, H., Thomson, E., Philcox, E., & Kelly, C. A. (2022) · doi:10.32388/uah9vu · Cited by 10
Headache disorders in patients with Ehlers-Danlos syndromes and hypermobility spectrum disorders
Mehta, D., Simmonds, L., Hakim, A. J., & Matharu, M. S. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1460352 · Cited by 8
Self-citationTinkle, B. T. (2020) · Wiley eBooks · doi:10.1002/9781119432692.ch25 · Cited by 8
Gastrointestinal medication burden among persons with the Ehlers‐Danlos syndromes
Dhingra, R., Bascom, R., Thompson, E., Francomano, C. A., & Schubart, J. R. (2021) · Neurogastroenterology & Motility · doi:10.1111/nmo.14077 · Cited by 7
Kersebaum, D., Baron, R., Gierthmühlen, J., & Forstenpointner, J. (2025) · Autonomic Neuroscience · doi:10.1016/j.autneu.2025.103306 · Cited by 9
Bourne, K. M., Nerenberg, K. A., Stiles, L. E., Shibao, C. A., Okamoto, L. E., Garland, E. M., Gamboa, A. C., Peltier, A., Diedrich, A., Biaggioni, I., et al. (2023) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17437 · Cited by 7
Self-citationSeverity classes in adults with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorder
Hakim, A. J. (2019) · Rheumatology · doi:10.1093/rheumatology/kez134 · Cited by 7
Self-citationMcGregor, G., Evans, B., Sandhu, H. K., Simmonds, J. V., Joshi, S., Devi, G., Zhupaj, A., Holliday, N., Pearce, G., Patel, C., et al. (2022) · Pilot and Feasibility Studies · doi:10.1186/s40814-022-01056-6 · Cited by 6
Postural Orthostatic Tachycardia Syndrome as a Manifestation of Post-COVID-19 Syndrome
Trisvetova, E. L. (2022) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2022-04-11 · Cited by 8
Petracek, L. S., Eastin, E. F., Rowe, I. R., & Rowe, P. C. (2022) · BMC Sports Science Medicine and Rehabilitation · doi:10.1186/s13102-022-00529-8 · Cited by 6
Self-citationNeurobiological and neuropsychological disturbance in EDS
Westerman, M., Kafkas, A., Parry‐Jones, A., Strong, S., Retzler, C., & Hallam, G. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1648702 · Cited by 6
Rattray, C. (2022) · Clinical Case Reports · doi:10.1002/ccr3.5887 · Cited by 5
Tinkle, B. T., & Atzinger, C. (2010) · Wiley eBooks · doi:10.1002/9780470893159.ch24 · Cited by 5
Candida and Long Covid: Mannan Not from HeavenPreprint
Chambers, P. W. (2024) · Qeios · doi:10.32388/je31eo.5 · Cited by 5
Alsakarneh, S., Ta’ani, O. A., Madi, M. Y., Syn, W., Ruffle, J. K., Aziz, Q., & Farmer, A. D. (2025) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70506 · Cited by 4
Considerations for lactation with Ehlers-Danlos syndrome: a narrative review
Francis, J., & Dickton, D. (2022) · International Breastfeeding Journal · doi:10.1186/s13006-021-00442-9 · Cited by 5
Treating pain in patients with Ehlers–Danlos syndrome
Börsch, N., Mücke, M., Maier, A., Conrad, R., Pantel, J. T., Sellin, J., Mani, K., & Chopra, P. (2024) · Der Schmerz · doi:10.1007/s00482-023-00778-7 · Cited by 4
Geenen, R., & Lumley (2018) · Utrecht University Repository (Utrecht University) · doi:10.3233/978-1-61499-878-5-i
Management of invasive ductal carcinoma in hypermobile Ehlers-Danlos syndrome: a case report
Deshpande, N., Murti, S., Singh, R., Coker, C., Rudra, S., Paudel, N., Fan, K. L., & Greenwalt, I. T. (2021) · Gland Surgery · doi:10.21037/gs-21-380 · Cited by 3
Recent advances in autonomic neurology: An overview
Nakane, S. (2021) · Neurology and Clinical Neuroscience · doi:10.1111/ncn3.12524 · Cited by 3
Daylor, V., Griggs, M., Weintraub, A., Byrd, R. L., Petrucci, T., Huff, M., Byerly, K., Fenner, R., Severance, S., Griggs, C., et al. (2025) · medRxiv · doi:10.1101/2025.06.05.25329074 · Cited by 3
Mathena, S. A., Allen, R. M., Laukaitis, C. M., & Andrews, J. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2024.1499582 · Cited by 2
A 21-year-old woman with Ehlers-Danlos syndrome and persistent lightheadedness
Qarajeh, R., Derbas, L., Abdallah, M., & Kureshi, F. (2021) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.88a.19137 · Cited by 2
Guerrerio, A. L., Mateja, A., MacCarrick, G. L., Fintzi, J., Brittain, E., Frischmeyer‐Guerrerio, P. A., & Dietz, H. C. (2024) · PLoS ONE · doi:10.1371/journal.pone.0298272 · Cited by 2
Black, W. R., Black, L. L., Goldstein‐Leever, A., Fox, L. S., Pratt, L. R., & Jones, J. T. (2024) · Rheumatology International · doi:10.1007/s00296-024-05676-4 · Cited by 2
Classification, nosology and diagnostics of Ehlers-Danlos syndrome
Hamel, B. C. J. (2019) · Journal of Biomedicine and Translational Research · doi:10.14710/jbtr.v5i2.4531 · Cited by 4
Seneviratne, S. L., Maitland, A. L., & Afrin, L. B. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38528 · Cited by 2
Steiner, L., Bodensteiner, A., & Johnson, N. (2023) · Journal of Orthopedic Research and Therapy · doi:10.29011/2575-8241.001313 · Cited by 2
Hamonet, C., Brissot, R., Amoretti, R., & Ducret, L. (2020) · Neuroscience and Neurological Surgery · doi:10.31579/2578-8868/122 · Cited by 2
Die Ehlers-Danlos-Syndrome mit Schwerpunkt auf dem hypermobilen Typ
Sturm, K., & Bohn, M. (2019) · Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen · doi:10.1007/s41970-019-0058-5 · Cited by 1
Shirvani, A., Shirvani, P., Jonah, U., Moore, B. E., & Holick, M. F. (2025) · Biomedicines · doi:10.3390/biomedicines13020469 · Cited by 2
Jones, E., & Carrieri, D. (2025) · Disability and Rehabilitation · doi:10.1080/09638288.2025.2517246 · Cited by 1
Chavarría-Aguilar, S., Zavaleta‐Monestel, E., & Anchía-Alfaro, A. (2025) · Cureus · doi:10.7759/cureus.93187 · Cited by 1
An Overview of Vascular Compression Syndromes and Associations with Autonomic Dysfunction: A Review
Davis, B. M., Rantanen, P., Seo, G., Thadani, S., Spencer, E. B., Hepworth, E. J., & Cutchins, A. C. (2026) · Biomedicines · doi:10.3390/biomedicines14030689 · Cited by 2
Butt, M. F., Dervin, H., Hoshino, S., Yazaki, E., Gerard, P., Sweis, R., Sifrim, D. A., Aziz, Q., Zárate-López, N., & Fikree, A. (2026) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2026.04.019 · Cited by 1
Morri, M., Tremosini, M., Forni, C., Moroni, A., Pedrini, E., Cecco, A. D., Gnoli, M., & Sangiorgi, L. (2026) · Pain Research and Management · doi:10.1155/prm/6664142 · Cited by 2
Rheumatology and Postural Tachycardia Syndrome
Hakim, A. J., Simmonds, J. V., & Kaul, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-54165-1_12 · Cited by 1
Self-citationESTUDO DE PREVALÊNCIA CARDIOVASCULAR EM CABO VERDE (ESTUDO PREVCARDIO.CV) - ILHA DO MAIO
COELHO, P. M. D. S. C., Rodrigues, F., & Adrião, L. L. D. S. (2021) · doi:10.22533/at.ed.5892117059 · Cited by 1
A Cross-Sectional Study of Cardiovascular Autonomic Reactivity in Ehlers-Danlos Syndrome
Alauddin, W., Alam, S., Mishra, M., Radke, P. M., Shree, R., Prajesh, B. R., Chaturvedi, A., Patil, A. D., Singh, T. K., & Ahmad, M. F. (2024) · Cureus · doi:10.7759/cureus.64542 · Cited by 1
Metadata
- Authors
- Hakim, A., O'Callaghan, C., De Wandele, I., Stiles, L., Pocinki, A., & Rowe, P.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Hakim, Alan
- Venue
- American Journal of Medical Genetics Part C: Seminars in Medical Genetics
- Publisher
- Wiley
- Published
- 2017-02-04
- Volume
- 175
- Issue
- 1
- Pages
- 168-174
- ISSN
- 1552-4868 (ISSN-L)
- 1552-4876
- OpenAlex
- W2586005000
- Cited by
- 163
- References
- 45
- Citations by year
- 2026: 14 · 2025: 20 · 2024: 17 · 2023: 14 · 2022: 19 · 2021: 40 · 2020: 15 · 2019: 11 · 2018: 5 · 2017: 7
- FWCI
- 2.20
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- American Journal of Medical Genetics Part C Seminars in Medical Genetics (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Syncope and Autonomic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Keywords
- cardiac autonomic dysfunction, orthostatic intolerance, orthostatic hypotension, postural orthostatic tachycardia syndrome, gastrointestinal motility disorders, bladder dysfunction, tilt table test, catecholamine levels, non-pharmacological treatment, pharmacotherapy, quality of life
- MeSH terms
- Cardiovascular Diseases, Ehlers-Danlos Syndrome, Humans, Disease Management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
